Muscarinic Agonists
- PMID: 31985923
- Bookshelf ID: NBK553130
Muscarinic Agonists
Excerpt
Muscarinic agonists are parasympathomimetic drugs and are indicated for ileus, urinary retention, glaucoma, Alzheimer disease, and other symptoms. This activity describes the indications, contraindications, and possible adverse effects of muscarinic agonists and how the interprofessional team can work together to improve outcomes using these agents. This activity will also highlight the different mechanisms of action of different muscarinic receptors in different parts of the body.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Zgourides GD. Bethanechol chloride as a suggested adjunct to prolonged in vivo exposure therapy in the treatment of paruresis. Percept Mot Skills. 1988 Feb;66(1):319-22. - PubMed
-
- Diokno AC, Koppenhoefer R. Bethanechol chloride in neurogenic bladder dysfunction. Urology. 1976 Nov;8(5):455-8. - PubMed
-
- Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med. 1999 Jan 25;159(2):174-81. - PubMed
-
- Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs. 1995 Jan;49(1):143-55. - PubMed
Publication types
LinkOut - more resources
Full Text Sources